Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05719116

A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Solli Distriktspsykiatriske Senter · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a feasibility study of a combined high intensity aerobic and strenght exercise program for persons with psychotic disorders. The feasibility of the protocol will be investigated, in addition to the participants subjective experience with the participation.

Detailed description

The aim of this study is to investigate the feasibility of a 16 week physical exercise intervention combining strenght and aerobic training in group for patients with psychotic disorders. In addition, the feasibility of the test protocol and participants subjective experience with the intervention will be investigated. Research shows positive effects of physical exercise for patients with psychotic disorders regarding maximal aerob training, maximal muscle strength, physical, cognitive and social functioning, and symptom levels. Effects and the degree of feasibility of physical exercise for patients with psychotic disorders are amplified by regarding their preferences and needs, and if they experience support and guidance during the intervention. Earlier studies have focused mostly on either strength og endurance training, or combined interventions of moderate intensity. We now want to investigate the feasibility of an invidually adjusted combined program of high intensity. After the intervention, participants will be interviewed about their experience with participating.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical exerciseThe physical exercise will be aerobic and strength training. The sessions will last app. 1 hour.

Timeline

Start date
2022-11-23
Primary completion
2026-12-31
Completion
2028-12-31
First posted
2023-02-08
Last updated
2025-09-24

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05719116. Inclusion in this directory is not an endorsement.